
Jacqueline M Kraveka DO
Pediatric Solid Tumor Oncology
Professor of Pediatrics, Division of Pediatric Hematology-Oncology MUSC
Join to view full profile
125 Doughty Street, Suite 520MSC 917Charleston, SC 29403
Phone+1 843-792-2957
Fax+1 843-985-4256
Dr. Kraveka is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jacqueline Kraveka, DO is a pediatric hematologist-oncologist based in Charleston, South Carolina, specializing in pediatric solid tumors. She earned her Doctor of Osteopathic Medicine degree from Nova Southeastern University College of Osteopathic Medicine in 1994, completed her pediatric residency at Nicklaus Children's Hospital, and went on to complete a fellowship in Pediatric Hematology/Oncology at the Medical University of South Carolina (MUSC).
Dr. Kraveka's clinical and research interests include neuroblastoma, pediatric sarcomas, precision oncology, clinical trial development, and personalized medicine for children with cancer. Her research has focused on neuroblastoma, precision medicine, and the role of bioactive sphingolipids in cancer biology. She has participated in the development and conduct of more than 20 clinical trials investigating novel therapies for childhood cancers.
A recognized leader in pediatric oncology, Dr. Kraveka has received numerous honors throughout her career, including recognition as one of Castle Connolly's Top Doctors, Top Hispanic and Latino Doctors, and Exceptional Women in Medicine. She is committed to advancing innovative therapies and precision medicine approaches to improve outcomes for children with cancer.
Education & Training
Medical University of South CarolinaFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Nicklaus Children's HospitalResidency, Pediatrics, 1994 - 1997
Nova Southeastern University College of Osteopathic MedicineClass of 1994
Certifications & Licensure
SC State License 1997 - 2027
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Hispanic and Latino Doctors Castle Connolly, 2023-2025
- Exceptional Women in Medicine Castle Connolly, 2017-2025
- Top Doctors Castle Connolly, 2014-2025
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 26
- Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Start of enrollment: 2003 Nov 01
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
Publications & Presentations
PubMed
- Bridging the Gap in Neuroblastoma Care: Consensus-Based Statements With Recommendations for Improved Patient and Caregiver Experiences.Vickie Buenger, Joseph Bauer, Jennifer Diamond, Maggie Fader, Shae Hansen
Pediatric Blood & Cancer. 2026-07-31 - 2 citationsComprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma.Timothy I Shaw, Stanley Pounds, Xueyuan Cao, Jing Ma, Gustavo Palacios
Leukemia. 2025-01-01 - 2 citationsComprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma.Timothy I Shaw, Stanley Pounds, Xueyuan Cao, Jing Ma, Gustavo Palacios
Research Square. 2024-03-28
Press Mentions
MUSC Pediatric Oncology Researcher Instrumental in Newly FDA-Approved Neuroblastoma DrugDecember 18th, 2023- Make-a-Wish Grants 4,000th Wish at Event at MUSC Shawn Jenkins Children’s HospitalNovember 22nd, 2022
Mayor Tecklenburg to Speak at MUSC Children’s Hospital for Childhood Cancer AwarenessSeptember 26th, 2016
Grant Support
- Role Of Ceramide In Human Neuroblastoma DifferentiationNational Cancer Institute2003–2007
Committees
- Member - NCI Community Oncology Research Program (NCORP) Representative, National Cancer Institute - Pediatric and Adolescent Solid Tumor Steering Committee (PASTSC) 2018 - 2025
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









